Incretin Effect of Glucagon-Like Peptide 1 Receptor Agonist Is Preserved in Presence of ABCC8/SUR1 Mutation in β-Cell
Year: 2012
Type: article
Abstract: ABCC8/SUR1-activating mutationsinduce neonatal diabetes (1) or otherdiabetes (1–4). Sulfonylurea treat-ment is unsuccessful in 15 % patients (2,3). Glucagon-like peptide 1 (GLP-1) en-hances insulin secretion by activating di-verse signaling pathways (4). This study aimed at exploring if the GLP-1 effect is retained when b-cell dysfunction is related to ABCC8 mutation. Three informed patients were included after approbation by the local ethics com-mittee. Patient1 (38years old, BMI21kg/m2, 6.2 % HbA1c) and 2 (64 years old, BMI 27 kg/m2, 7.4 % HbA1c) were diagnosed at ages 15 and 17 years as having type 1 di-abetes and treated with insulin for years,
Source: Diabetes Care
DOI: 10.2337/dc12-0535
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: Eli Lilly and Company
OpenAlex ID: W2085437797
